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The electrical stimulation generated by the Cochlear Implant (CI) may improve the neural synchrony 
and hence contribute to the development of auditory skills in patients with Auditory Neuropathy / 
Auditory Dyssynchrony (AN/AD). 
Aim: Prospective cohort cross-sectional study to evaluate the auditory performance and the 
characteristics of the electrically evoked compound action potential (ECAP) in 18 children with AN/
AD and cochlear implants. 
Material and methods: The auditory perception was evaluated by sound field thresholds and 
speech perception tests. To evaluate ECAP’s characteristics, the threshold and amplitude of neural 
response were evaluated at 80Hz and 35Hz. 
Results: No significant statistical difference was found concerning the development of auditory 
skills. The ECAP’s characteristics differences at 80 and 35Hz stimulation rate were also not statistically 
significant. 
Conclusion: The CI was seen as an efficient resource to develop auditory skills in 94% of the AN/
AD patients studied. The auditory perception benefits and the possibility to measure ECAP showed 
that the electrical stimulation could compensate for the neural dyssynchrony caused by the AN/AD. 
However, a unique clinical procedure cannot be proposed at this point. Therefore, a careful and 
complete evaluation of each AN/AD patient before recommending a Cochlear Implant is advised. 
Clinical Trials: NCT01023932
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INTRODUCTION
The approach for habilitating and rehabilitating 
patients with auditory neuropathy/auditory dys-synchrony 
(AN/AD) has raised diverging questions and opinions, 
because these individuals continue to be placed in the 
special cases group for cochlear implants. The term au-
ditory neuropathy has been used generically to name 
discrepancies between the cochlear and neural functions 
of the auditory system.
AN/AD has been described in the literature as a 
change in neural synchronism whereby the function of 
outer hair cells is preserved while afferent neural trans-
mission is compromised. However, to this date the exact 
injury site has not been demonstrated by current methods 
in clinical practice.
AN/AD can significantly affect speech understan-
ding and production. Thus, adequate habilitation and reha-
bilitation is needed especially in children, who go through 
critical hearing and language development periods.
Individual hearing aids have shown poor results; 
amplification may improve the detection of sounds but 
does not provide any benefit for the development of 
speech discrimination, recognition, and understanding.1-3
Other communication strategies - communication 
by gestures, lip reading, and frequency modulated (FM) 
systems - have been suggested for habilitation and reha-
bilitation in this group of patients4,5.
About one third of AN/AD patients present severe 
to profound hearing loss, and are thus candidates for 
cochlear implants6.
Cochlear implants are indicated in this group becau-
se this electronic device can partially replace the function 
of auditory sensory cells. These devices stimulate the au-
ditory nerve directly, thereby improving neural synchrony 
and supporting language and hearing development7-9.
At the same time, the compound action potential 
of the electrically evoked auditory nerve (ECAP) or neural 
response in cochlear implant users can objectively demons-
trate changes in hearing following electrical stimulation of 
the auditory system in AN/AD patients.
Because the electrical stimulation of cochlear im-
plants may improve neural synchrony and support audi-
tory ability development, the purpose of this study was to 
assess hearing performance and ECAP features in a group 
of AN/AD children with cochlear implants.
MATERIAL AND METHODS
A cross-sectional cohort study was undertaken of 
18 AN/AD children with cochlear implants for at least six 
months that participated in two different cochlear implant 
programs in São Paulo state.
The institutional ethics review board for research in 
human being approved this study (no. 316/2005 UEP-CEP).
Parents and caretakers of participants were infor-
med about the procedures, and signed a free informed 
consent form.
Regarding the inclusion criteria, the surgical indica-
tion for cochlear implants in children with prelingual hea-
ring loss is made in both centers according to international 
criteria, namely: age around 1 year; cochlear permeability 
for inserting the electrodes surgically; bilateral severe to 
profound and/or profound sensorineural hearing loss; 
auditory threshold with normal amplification over 60 dB at 
500, 1,000, and 2,000 Hz after intense and effective auditory 
habilitation; limited benefit for auditory abilities with the 
use of hearing aids; absence of intellectual or emotional 
deficits; motivated family for using cochlear implants and to 
develop favorable communication attitudes in the children; 
adequate family expectation about the results of cochlear 
implants; participation of children in auditory habilitation 
and rehabilitation programs in their city of origin.
Preoperative imaging exams (magnetic resonance 
imaging and computed tomography of the temporal bones) 
were normal in all subjects.
Other clinical peculiarities not mentioned above 
were analyzed in each patient and defined as special cases.
Cochlear implants are not indicated in prelingual 
hearing impaired children also according to international 
criteria in both cochlear implant programs from which data 
were gathered, as follows: severe neurological conditions 
associated with hearing loss; medical or psychological 
conditions that contraindicate surgery; hearing loss due 
to cochlear or auditory nerve agenesis, or central injuries; 
active middle ear infection; unreal family expectations 
about the benefits, results, and limits of cochlear implants.
The audiological and electrophysiological features 
of AN/AD in the study sample were as follows: normally 
functioning OHCs identified by otoacoustic emissions 
(OAE) and/or cochlear microphonism; neural alterations 
in which brainstem auditory evoked potentials were ma-
rkedly altered or absent; altered audiometric thresholds; 
limited results with conventional amplification in hearing 
and language development.
The age at which surgery was done in the study 
sample ranged from 1 year and 8 months to 6 years and 
11 months (mean - 3 years and 8 months). The duration 
of cochlear implant use ranged from 10 months to 3 years 
and 5 months.
The cochlear implant brand and model in the study 
subjects were not taken into account in the inclusion/
exclusion criteria. Nevertheless, all subjects used the Nu-
cleus 24 cochlear implant (Cochlear Corporation) and the 
electrodes were completely inserted.
Based on Davis and Silverman’s (1970)10 hearing loss 
classification, 9 subjects (50%) had profound hearing loss, 
and 9 subjects (50%) had severe hearing loss as evidenced 
by their audiometric thresholds.
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Data were taken from files of prenatal, perinatal, 
and postnatal registries, the etiology of hearing loss, audio-
logic and electrophysiologic tests (pure tone audiometry, 
OAE, impedance testing, BAEP, and presence of cochlear 
microphonism), and the cochlear implant surgery.
Behavioral assessment of hearing (play audiometry 
to measure the free field audiometry threshold at 500 Hz, 
1 kHz, 2 kHz, and 4 kHz while using cochlear implants) 
and speech perception assessment (test adapted to age and 
hearing abilities, adapted into Portuguese for each age level) 
were used to test hearing perception.
The following procedures were used for testing 
speech perception: procedure to assess children with 
profound hearing loss11 adapted from the Glendonald 
Auditory Screening Procedure (GASP), and perception of 
speech sounds in children - word list12.
The nature of hearing ability tasks in study subjects 
was classified according to the observed hearing abilities 
in the speech perception assessment procedures.
The category “detection of sounds” was used in 
children with results showing limited speech perception 
that were able to carry out only Test 1 of the GASP.
The closed set category was done in children that 
were able to carry out Test 5 of the GASP, in which chil-
dren are presented with alternative answers13.
Children that were able to carry out Test 6 of the 
GASP - and therefore the list of disyllables - were classified 
in the open set category. In this test, children had no choice 
of answers, and required more complex hearing abilities13.
Impedance telemetry or reverse telemetry or bidirec-
tional telemetry was done in all stimulation modes present 
in the Nucleus 24 cochlear implant system to assess the 
neural response; the aim was to analyze the integrity of 
the intracochlear electrodes.
The impedance values of intracochlear electrodes 
20, 15, 10, and 5 were evaluated.
Electrodes with altered impedance values - indica-
ting a short circuit or open circuit - were excluded from the 
evaluation. The adjacent apical electrode (that had normal 
impedance values) was then used in the research protocol.
Four out of 72 electrodes had altered impedance 
values; therefore, adjacent apical electrodes were used.
The ECAP was carried out with electrodes 20, 15, 
10 and 5, which were in the surgically inserted electrodes.
The parameters that were applied in recording the 
neural response were taken from published recommen-
dations14-16.
ECAP threshold measurements were taken at the 
80 and 35Hz stimulation frequencies to assess possible 
changes in the characteristics of the neural response as 
the stimulation frequency is reduced. The same neural 
response recording parameters were used for the two 
tested stimulation frequencies. ECAP responses were 
classified according to the following parameters: presence 
of N1 (measurable peak); presence of P1/P2 (measurable 
peak); response morphology; response reproducibility; 
and consecutive valid recordings.
Neural response amplitude and threshold value 
criteria were applied to assess the recordings qualitatively 
and quantitatively.
Two-way analysis of variance was applied to evalua-
te correlations between age at surgery, duration of cochlear 
implant use, and speech perception results.
Fisher’s exact test was applied to check the relation 
between TOAE results and hearing abilities.
Repeated measures analysis of variance was applied 
to study the relationship between mean speech frequency 
auditory thresholds (0.5, 1 and 2 kHz), and open and 
closed set speech recognition results in each subject. Free 
field auditory threshold means at each frequency were 
marked with triangles at different tested frequency ranges.
Repeated measures analysis of variances was also 
applied to analyze neural response amplitude and threshol-
ds at 35 and 80 Hz.
RESULTS
The causes of hearing loss in the study sample were 
as follows: association of multiple indicators of hearing 
loss at birth (or multifactorial causes) in 50% of subjects; 
unknown or idiopathic in 44% of subjects; and congenital 
rubella in 6% of subjects.
Speech perception results (speech detection, closed 
set auditory recognition, and open set auditory recognition) 
were distributed in the study population as follows: closed 
set speech recognition - 61% of subjects; open set speech 
recognition - 33% of subjects; and detection of sounds 
only in 6% of subjects.
There were no statistically significant differences 
among the mean ages at surgery, the duration of use of co-
chlear implants, and speech recognition auditory abilities.
There was no statistically significant relationship 
in speech perception performance for open and closed 
set speech recognition and the presence of OAE before 
surgery in the right ear (p=0.304) and left ear (p=0.620).
Figure 1 shows the results of free field auditory 
thresholds at 0.5, 1, 2 and 4 kHz in each study subject.
There were no statistically significant differences 
among the means of pure tone thresholds at speech fre-
quencies or in open and closed set speech recognition 
abilities (p=0.485).
Neural response recordings were: 83% of mea-
surements in electrode 20, followed by 83% of positive 
response in electrode 15, then 88% in electrode 10, and 
94% of recordings in electrode 5.
Figure 2 shows a comparison of neural response 
visual thresholds at 35 and 80 Hz (stimulus frequencies), 
as observe in electrodes 20,15, 10 and 5.
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among the neural response amplitude means at stimu-
lus frequencies of 35 and 80 Hz (p=0.969) in all tested 
electrodes.
Figure 1. Free Field Pure Tone Audiometry - Results of free field auditory 
thresholds (dB) at 0.5, 1, 2, and 4 kHz.
Figure 2. Visual Neural Response Thresholds - Results of means ± 
standard errors of the visual neural response threshold in electrodes 
20, 15, 10, and 5, at 35 and 80 Hz stimulation frequencies.
Figure 3. Neural Response Amplitude - Results of means ± standard 
errors of the neural response amplitude in electrodes 20, 15, 10, and 
5, at 35 and 80 Hz stimulation frequencies.
A difference was found in the threshold means of 
four electrodes (p=0.000) at both 35 Hz and 80 Hz stimulus 
frequencies.
Specific analysis per electrode revealed no differen-
ces in visual threshold means at 35 and 80 Hz stimulus 
frequencies (p=0.566).
The results of comparing electrodes revealed that 
the visual threshold mean was lower in electrode 20 com-
pared to the other electrodes (p=0.000). The visual mean 
of electrode 15 was lower than that of electrode 10. A 
comparison of the visual threshold means in electrodes 
10 and 5 yielded a marginal p value (p=0.051).
The neural response amplitude ranged from 21.8 
mV to 128 mV in electrodes 20, 15, 10, and 5 at a stimulus 
frequency of 35 Hz. The neural response amplitude varied 
from 27.7 mV to 103.1 mV at a stimulus frequency of 80 
Hz among the tested electrodes.
Figure 3 shows the mean neural response amplitu-
de values in electrodes 20, 15, 10, and 5 at 35 and 80 Hz 
stimulus frequency.
There were no statistically significant differences 
A comparison of neural response amplitudes among 
electrodes revealed no statistically significant differences 
among the neural response amplitude means in electrodes 
20,15, 10, and 5 (p=0.096) at stimulus frequencies of 35Hz 
and 80Hz (p=0.527).
DISCUSSION
The variable results attained in users of cochlear im-
plants is closely related with intrinsic factors pertaining to 
the hearing system of each individual and extrinsic factors 
such as motivation for using the device, family support, 
habilitation and rehabilitation method, among others.
In the AN/AD population, these widely diverging 
results may reflect degrees of disease or changes along 
auditory pathways.
Secondary AN/AD to neonatal diseases was encoun-
tered in 50% of the study subjects. Complications during 
and/or after birth as related factors in the diagnosis of this 
disease have been described in the literature17-22.
The difficulties for establishing the etiology of AN/
AD are evident in this study - 44% of subjects had AN/
AD of unknown causes. A previous study22 also reported 
a similar rate: 40% of 70 patients had idiopathic AN/AD.
Congenital rubella as a cause of AN/AD has not 
been described in the literature, possibly because this 
disease has been controlled in developed countries by 
immunization of women of reproductive age.
We found encouraging results of using electrical 
stimulation in AN/AD patients; hearing abilities improved 
significantly in 94% of our study subjects. Promising results 
of cochlear implant use in AN/AD patients have already 
been published7,20,23,24.
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Thus, cochlear implants appeared to help develop 
auditory abilities irrespective of a diagnosis of AN/AD. This 
finding concurs with those of other published studies7,23.
Speech perception results were better the longer 
cochlear implants were used, even though there were no 
statistically significant differences in duration of cochlear 
implant use and open and closed set speech recognition. 
Other authors have also pointed out a gradual develop-
ment of speech perception abilities following cochlear im-
plants use for some time in different groups of children25-33.
The mechanism by which OAE deteriorate or are 
lost in AN/AD patients remains unknown; no significant 
relationship between absence and/or possible loss of OAE 
and any specific changes in AN/AD were found. Our re-
sults showed that the presence of OAE preoperatively did 
not seem to be a determining variable for the development 
of hearing abilities, given that no significant correlation 
was found between the presence of OAE in right and left 
ears and open and closed set speech recognition abilities.
Thus, the presence of OAE preoperatively did not 
necessarily mean a better prognosis after placing cochlear 
implants. Lack of a significant correlation between the 
presence of OAE and speech perception results in hearing 
aid users has already been published in the literature34.
All study subjects had typical mean audiometry 
threshold values for users of cochlear implants. Minor 
variations may occur because audiometry threshold me-
asurements are subjective - attention, concentration, and 
motivation during the two or more test situations may 
result in small differences.
A few studies have reported the neural response 
recording features of ECAP in AN/AD patients; our study 
sample had no specific aspects related to this potential.
No specific features were found in the ECAP in 
the study sample (children with AN/AD). This condition, 
therefore, did not appear to be a determining factor for 
ECAP recordings.
Our analysis was based on existing studies on 
ECAP in cochlear implant users in general because of the 
similarity between ECAP findings in our study sample and 
in the clinical population of cochlear implants users, and 
because there have been few studies describing specifically 
the neural response characteristics in AN/AD patients.
Neural responses were present in over 80% of our 
recordings. Similar possibilities in ECAP recordings have 
been described elsewhere35.
Charasse et al. (2004)36 have suggested that the 
stimulus frequency for recording ECAP can affect the 
number of valid recording and the neural response quality 
in cochlear implant users.
Using lower stimulus frequencies in AN/AD cases 
could presumably generate more robust neural respon-
ses; thus, altered neural synchrony could be the cause of 
speech perception difficulties.
The hypothesis that the hearing system responds 
more slowly in AN/AD patients because of altered audi-
tory nerve neuron triggering, and that the resulting lower 
stimulus presentation rate generates more evident neural 
responses, motivated us to measure the neural response 
characteristics at stimulus frequencies of 35 and 80 Hz.
However, no statistically significant differences be-
tween visual neural response thresholds were found when 
comparing the two stimulus frequencies. These findings 
corroborate previous papers35, in which no significant 
differences in ECAP recordings at 35 Hz and 80 Hz were 
found in adult cochlear implant users.
Similarly, there were no statistically significant di-
fferences in neural response amplitudes as the stimulus 
frequency was reduced to 35 Hz. However, the mean 
neural response amplitude values were higher at 35 Hz 
in all electrodes, indicating better neural response mea-
surements at this stimulus frequency. Other authors have 
also reported that neural response amplitudes tended to 
increase at lower stimulus frequencies37.
Similarities in neural response characteristic at 
stimulus frequencies of 35 and 80 Hz suggests that the 
auditory system in the study population retrieved the 
temporal properties in coded information, following elec-
trical stimulation, irrespective of the stimulus frequency. 
Significant differences in the quality of neural responses 
have been described in the literature only for recordings 
obtained at stimulus frequencies over 150 Hz36. Further 
studies investigating neural response characteristics in 
AN/AD patients at stimulus frequencies over 80 Hz may 
contribute to the analysis of neural response recording 
quality as stimulus frequencies are raised significantly to 
values over 150 Hz.
In the present study, the benefits for hearing per-
ception seen in AN/AD children that use cochlear implants 
- and the possibility of recording ECAP - have shown that 
electric stimulation from cochlear implants compensated 
for the altered neural synchrony caused by AN/AD.
Except for one study subject in our series, cochlear 
implant use in AN/AD children resulted in comparable 
development of hearing abilities to children without AN/
AD that also used cochlear implants. Intrinsic variables 
that are inherent to the pathophysiology of AN/AD did 
not appear to affect the development of hearing abilities 
in AN/AD patients following electric stimulation. AN/AD 
children do not require specific adjustments of program-
ming parameters for the speech processor.
It should be noted that the results of cochlear 
implant use in AN/AD patients were closely related with 
the site of the alteration. However, it is sill not possible to 
define exactly the injury site to specify which AN/AD cases 
could benefit most from cochlear implants. Encouraging 
results in our study sample related to the development of 
hearing abilities in AN/AD patients using cochlear implants 
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suggest that neural function is preserved. Altered neural 
synchrony in these cases was possibly due to altered ou-
ter hair cells and/or the synapses of these cells with the 
auditory nerve.
A longitudinal study of AN/AD patients that use 
cochlear implants may clarify specific nuances in the 
rehabilitation process of this group as these patients use 
cochlear implants. At the same time, a test protocol that 
includes an assessment of hearing abilities in the presence 
of competing noise, of language abilities, and of speech 
production, may help establish the specific clinical features 
of AN/AD patients that use cochlear implants.
CONCLUSION
In this study, cochlear implants are effective mea-
sures for developing auditory abilities in 94% of AN/AD 
subjects. Use of a reduced stimulation frequency (35 Hz) 
did not result in statistically significant changes in neural 
response amplitudes and thresholds.
However, a common approach cannot yet be defi-
ned and adopted, given the heterogeneous nature of our 
clinical group of cases.
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